Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-18-023031
Filing Date
2018-09-12
Accepted
2018-09-12 16:09:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1022676
2 GRAPHIC gk2epwhx2qzv000002.jpg GRAPHIC 1946
3 GRAPHIC gk2epwhx2qzv000001.jpg GRAPHIC 3610
4 GRAPHIC gk2epwhx2qzv000003.jpg GRAPHIC 3687
  Complete submission text file 0001564590-18-023031.txt   1036828
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-208376 | Film No.: 181066968
SIC: 2834 Pharmaceutical Preparations